Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

MyNCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1974 1
1975 2
1976 15
1977 43
1978 26
1979 35
1980 38
1981 47
1982 56
1983 43
1984 40
1985 53
1986 40
1987 42
1988 63
1989 58
1990 57
1991 56
1992 66
1993 62
1994 72
1995 89
1996 106
1997 77
1998 113
1999 102
2000 107
2001 97
2002 117
2003 133
2004 150
2005 155
2006 159
2007 166
2008 167
2009 116
2010 103
2011 93
2012 130
2013 100
2014 96
2015 118
2016 95
2017 78
2018 82
2019 37
2020 1
Text availability
Article attribute
Article type
Publication date

Search Results

3,455 results
Results by year
Filters applied: . Clear all
Page 1
SR9009 has REV-ERB-independent effects on cell proliferation and metabolism.
Dierickx P, Emmett MJ, Jiang C, Uehara K, Liu M, Adlanmerini M, Lazar MA. Dierickx P, et al. Proc Natl Acad Sci U S A. 2019 Jun 18;116(25):12147-12152. doi: 10.1073/pnas.1904226116. Epub 2019 May 24. Proc Natl Acad Sci U S A. 2019. PMID: 31127047 Free PMC article.
FXR modulators for enterohepatic and metabolic diseases.
Wang H, He Q, Wang G, Xu X, Hao H. Wang H, et al. Expert Opin Ther Pat. 2018 Nov;28(11):765-782. doi: 10.1080/13543776.2018.1527906. Epub 2018 Oct 8. Expert Opin Ther Pat. 2018. PMID: 30259754 Review.
Estrogen Receptor β as a Pharmaceutical Target.
Warner M, Huang B, Gustafsson JA. Warner M, et al. Trends Pharmacol Sci. 2017 Jan;38(1):92-99. doi: 10.1016/j.tips.2016.10.006. Epub 2016 Dec 13. Trends Pharmacol Sci. 2017. PMID: 27979317 Review.
Targeting xenobiotic receptors PXR and CAR in human diseases.
Banerjee M, Robbins D, Chen T. Banerjee M, et al. Drug Discov Today. 2015 May;20(5):618-28. doi: 10.1016/j.drudis.2014.11.011. Epub 2014 Nov 20. Drug Discov Today. 2015. PMID: 25463033 Free PMC article. Review.
3,455 results
Jump to page
Feedback